Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH

JSON

Mardinoglu A, Kim W, Li M, Liao X, Özmen S, Yıldız E, Saraçoğlu M, Baba C, Celikezen F, Atalay S, Akkuş A, Alper F, Jin H, Yang H, Iqbal S, Sebhaoui J, Ashraf S, Belmen B, Boren J, Uhlén M, Zhang C, Turkez H

- - (-) - [2025-09-25; online 2025-09-25]

DOI 10.21203/rs.3.rs-7114368/v1

Crossref 10.21203/rs.3.rs-7114368/v1